Search This Blog

Tuesday, July 30, 2019

Utah Medical Products reports Q2 results

Utah Medical Products (NASDAQ:UTMD): Q2 GAAP EPS of $0.94.
Revenue of $11.85M (+8.0% Y/Y)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.